Analystreport

Orchard Therapeutics PLC - (NASDAQ: ORTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $26.00 to $17.00. They now have an "overweight" rating on the stock.

Orchard Therapeutics plc - American Depositary Shares  (ORTX) 
Last orchard therapeutics plc - american depositary shares earnings: 2/27 07:00 am Check Earnings Report